MedCity Knowledge Hub
May 16, 2024 · Welcome to the MedCity News Knowledge Hub. Our library of free downloadable content includes white papers, webinars, product guides, case studies, industry analysis and much more, provided by experts and vendors within the healthcare industry. By downloading the content, you may be contacted by the provider.
5 challenges healthcare faces in 2022 and beyond - MedCity News
Jan 12, 2022 · 5 challenges healthcare faces in 2022 and beyond. Boston Consulting Group published a new report that identifies five challenges facing healthcare in the upcoming 3 to 5 years as a result of the ...
Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease …
May 28, 2024 · Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction.
FDA Approves New First-Line Med for Pancreatic Cancer as Drug’s …
Feb 14, 2024 · Pancreatic cancer continues to be one of the most difficult-to-treat cancers. An Ipsen drug is now approved as a first-line therapy, moving it up in the treatment hierarchy for this type of cancer.
New CMS rules put the focus on informed patient choice
Dec 9, 2019 · With the final rule, CMS has signaled to hospitals that they must provide patients with informed choice – not just any choice – of post-acute providers. New discharge planning requirements of ...
Physical therapy is about to witness the next innovation wave
Nov 17, 2021 · New advances in sensing technology are set to spur further innovation in the physical-therapy field, and help fill the gap in guidance that exists in between in-clinic sessions. By Lukas-Karim ...
A First for Fatty Liver: FDA Approves Madrigal Pharma NASH Drug
Mar 14, 2024 · Learn how Madrigal Pharma made history with the first FDA-approved drug for NASH, a common and serious fatty liver disease, on medcitynews.com.
The Value-based Care Throughline to Healthcare Quality and Safety
May 27, 2024 · At the heart of this crisis lies an opportunity—a throughline that connects quality, safety, and the transition to value-based care. By prioritizing patient engagement and communication ...
Amgen Osteoporosis Drug Prolia Is Hit With FDA’s Strictest Warning
By Frank Vinluan on January 21, 2024. A blockbuster Amgen drug for osteoporosis now carries the FDA’s strictest warning that its use can lead to dangerously low levels of calcium in the blood ...
Evaluation of the use of midline peripheral catheters for the …
Jun 10, 2021 · The purpose of this study was to assess the processes and outcomes of using the MC to sample blood for laboratory testing. We aimed to evaluate the MC in an acute care setting for hemolysis rates ...